IntroductionAmyloid imaging is a tool that has recently become available to dementia specialists evaluating patients with possible Alzheimer's disease. Studies have assessed the impact of amyloid imaging on diagnostic and treatment decisions, but patient and family perspectives have received less attention.MethodsTo examine how amyloid imaging affects the diagnostic experience of patients and families, we interviewed members of 26 patient-caregiver dyads with whom a neurologist discussed the option of amyloid positron emission tomography.ResultsMost participants who chose to undergo amyloid imaging would choose to do so again. Regardless of the scan outcome, patients and caregivers commonly expressed relief on learning the scan results. Som...
Importance: Previous studies have evaluated the diagnostic effect of amyloid positron emission tomog...
Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the ea...
Amyloid plaques, along with neurofibrillary tangles, are a neuropathologic hallmark of Alzheimer dis...
IntroductionAmyloid imaging is a tool that has recently become available to dementia specialists eva...
BackgroundMild cognitive impairment (MCI) has an uncertain etiology and prognosis and may be challen...
ImportanceClinical guidelines currently recommend against amyloid imaging for cognitively unimpaired...
INTRODUCTION: Few studies to date have explored patient and caregiver views on the clinical use o...
Detection of Alzheimer's disease (AD) in an early stage is receiving increasing attention for a numb...
IntroductionGiven mounting calls to disclose biomarker test results to research participants, we exp...
Abstract Background Mild cognitive impairment (MCI) has an uncertain etiology and prognosis and may ...
IntroductionThe objective of this study was to develop a process to maximize the safety and effectiv...
Introduction This study aims to assess patients' and caregivers' views on and experiences with (1) d...
Background/ObjectivesDisclosure of Alzheimer’s disease (AD) risk information to cognitively unimpair...
Importance: Previous studies have evaluated the diagnostic effect of amyloid positron emission tomog...
IntroductionRecent studies suggest that Alzheimer’s disease (AD) biomarker disclosure has no discern...
Importance: Previous studies have evaluated the diagnostic effect of amyloid positron emission tomog...
Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the ea...
Amyloid plaques, along with neurofibrillary tangles, are a neuropathologic hallmark of Alzheimer dis...
IntroductionAmyloid imaging is a tool that has recently become available to dementia specialists eva...
BackgroundMild cognitive impairment (MCI) has an uncertain etiology and prognosis and may be challen...
ImportanceClinical guidelines currently recommend against amyloid imaging for cognitively unimpaired...
INTRODUCTION: Few studies to date have explored patient and caregiver views on the clinical use o...
Detection of Alzheimer's disease (AD) in an early stage is receiving increasing attention for a numb...
IntroductionGiven mounting calls to disclose biomarker test results to research participants, we exp...
Abstract Background Mild cognitive impairment (MCI) has an uncertain etiology and prognosis and may ...
IntroductionThe objective of this study was to develop a process to maximize the safety and effectiv...
Introduction This study aims to assess patients' and caregivers' views on and experiences with (1) d...
Background/ObjectivesDisclosure of Alzheimer’s disease (AD) risk information to cognitively unimpair...
Importance: Previous studies have evaluated the diagnostic effect of amyloid positron emission tomog...
IntroductionRecent studies suggest that Alzheimer’s disease (AD) biomarker disclosure has no discern...
Importance: Previous studies have evaluated the diagnostic effect of amyloid positron emission tomog...
Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the ea...
Amyloid plaques, along with neurofibrillary tangles, are a neuropathologic hallmark of Alzheimer dis...